Emerging high-dimensional atlases are synthesized to reframe macrophage–T-cell crosstalk from simple ligand–receptor interactions into a spatially organized ecological model to provide actionable translational insights for targeting macrophage vulnerabilities, guiding biomarker-driven combinatorial immunotherapies, and overcoming immune resistance in cervical cancer.
Abstract
Immunotherapy has transformed the therapeutic landscape of advanced cervical cancer, yet clinical benefit remains limited by a highly heterogeneous and immunosuppressive tumor microenvironment. Traditional paradigms, including binary M1/M2 macrophage polarization and models that interpret T-cell dysfunction solely through checkpoint expression, are insufficient to capture the localized intercellular dynamics that drive immune evasion. Recent advances in single-cell and spatial multi-omics have fundamentally reshaped our understanding of this landscape. In this review, we synthesize emerging high-dimensional atlases to reframe macrophage–T-cell crosstalk from simple ligand–receptor interactions into a spatially organized ecological model. We highlight the paradigm shift toward highly resolved myeloid programs, particularly SPP1+ and C1QC+ macrophage states, and discuss how these programs interact with stromal barriers, regulatory T cells, and metabolic checkpoints to restrict, exclude, or functionally constrain effector T cells within suppressive niches. Crucially, we position persistent high-risk human papillomavirus infection not merely as an initiating carcinogenic trigger, but as an upstream and continuous programmer that rewires innate immune sensing, including context-dependent cGAS–STING-related circuits, to stabilize local immune tolerance throughout disease progression. Finally, we propose translational strategies for distilling complex multi-omic atlases into pathology-compatible prognostic and predictive biomarker signatures. Ultimately, by deciphering these spatially organized networks, this review aims to provide actionable translational insights for targeting macrophage vulnerabilities, guiding biomarker-driven combinatorial immunotherapies, and overcoming immune resistance in cervical cancer.
This work reframes macrophage efferocytosis as a spatially and temporally constrained determinant of immune contexture with important implications for precision immunotherapy, combination design, and trial optimization.
Shan-Yi Li, Ji-Lei Li, Zhen-Yu Zhang et al.· Cancer Medicine· 0 citations
This review proposes the concept of spatially organized RCD-immune coupling as a hypothesis-generating framework and argues that RCD modalities are not uniformly distributed across tumors, but are influenced by regional microenvironmental constraints, including metabolic zonation, hypoxia, and mechanical stress.
This chapter provides an integrated framework for understanding TAM biology across multiple regulatory dimensions, including ontogeny, plasticity, metabolism, epigenetic control, and spatial niche organization, and synthesizes current and emerging therapeutic strategies targeting TAM recruitment, survival, reprogrammin...
Atif Elnaggar, Abdelrahman Elnaggar· Advances in Cancer Research· 0 citations
A spatially organized POSTN⁺ CAF–SPP1⁺ macrophage niche that may contribute to stromal remodeling, CD8⁺ T-cell exclusion, and potentially reduced immunotherapy benefit in LUAD is defined.
Ankang Zhu, Jian-Yuan Huang, Juan Zhang et al.· Journal of Translational Med...· 0 citations
A narrative review uses spatial immune niches as a framework for interpreting immunotherapy resistance in gastric cancer and highlights clinically relevant niche states, including lymphoid-organized inflamed, inflamed-but-suppressed, stromal-excluded, myeloid-dominant, vascular/hypoxic, target-antigen-associated, and p...
Zi-Qiang Ling, Renzhe Tang, Bo Yuan et al.· Frontiers in Immunology· 0 citations